Assistant Professor of Urologic Surgery and Health Policy
Urology
Dr. Matthew J. Resnick, MD
|
|
Give Review
Matthew Resnick practices Urology. He attended Perelman School of Medicine at the University of Pennsylvania. Dr. Matthew J. Resnick is a published MD. He has 41 publications published. The most current publication "Doing More for More: Unintended Consequences of Financial Incentives for Oncology Specialty Care." Dr. Matthew J. Resnick accepts Medicare payments and is registered with Medicare.gov.
Publications
- Doing More for More: Unintended Consequences of Financial Incentives for Oncology Specialty Care.
- The Comparative Harms of Open and Robotic Prostatectomy in Population Based Samples.
- Increasing Use of Observation among Men at Low Risk for Prostate Cancer Mortality.
- Prostate Cancer survivorship care guideline: american society of clinical oncology clinical practice guideline endorsement.
- Gender, Race, and Variation in the Evaluation of Microscopic Hematuria Among Medicare Beneficiaries.
- Impact of complications and hospital-free days on health related quality of life 1 year after radical cystectomy.
- Predictors of outcome in Bladder cancer.
- Influence of Age on Incident Diabetes and Cardiovascular Disease Among Prostate Cancer Survivors Receiving Androgen Deprivation Therapy.
- The Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research.
- Multiple Repeat Prostate Biopsies and the Detection of Clinically Insignificant Cancer in Men With Large Prostates.
- The Right Triangle.
- Developments and controversies in the management of noninvasive Bladder cancer.
- Locoregional small cell carcinoma of the Bladder: clinical characteristics and treatment patterns.
- Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate Cancer treatment.
- Trends in the Use of Perioperative Chemotherapy for Localized and Locally Advanced Muscle-invasive Bladder Cancer: A Sign of Changing Tides.
- Using a population-based observational cohort study to address difficult comparative effectiveness research questions: the CEASAR study.
- Incidence and Predictors of Understaging in Patients with Clinical T1 Urothelial Carcinoma Undergoing Radical Cystectomy.
- Urological Cancer: Walking the tightrope of survival and quality of life with ADT.
- Positive surgical margins at radical Prostatectomy: much ado about nothing?
- Factors associated with satisfaction with prostate Cancer care: results from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
- Management of superficial and muscle-invasive urothelial cancers of the Bladder.
- Optimizing outcomes for octogenarians with invasive Bladder cancer: One size does not fit all.
- Long-term functional outcomes after treatment for localized prostate Cancer.
- Patient selection essential in optimizing the benefit of radical prostatectomy for patients with organ-confined prostate Cancer.
- Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate Cancer who would qualify for active surveillance.
- Repeat prostate biopsy and the incremental risk of clinically insignificant prostate Cancer.
- A thorough pelvic lymph node dissection in presence of positive margins associated with better clinical outcomes in radical cystectomy patients.
- The impact of residency match information disseminated by a third-party website.
- Robotic ureterocalicostomy in the pediatric population.
- Hydronephrosis is an independent predictor of poor clinical outcome in patients treated for muscle-invasive transitional cell carcinoma with radical cystectomy.
- A case of synchronous bilateral Testicular seminoma.
- Involvement of the mitogen-activated protein kinase cascade in peroxynitrite-mediated arachidonic acid release in vascular smooth muscle cells.
- Tyrosine nitration in prostaglandin H(2) synthase.
- Defining pathological variables to predict biochemical failure in patients with positive surgical margins at radical Prostatectomy: implications for adjuvant radiother...
- Synchronous metastatic Renal cell carcinoma to the genitourinary tract: two rare case reports and a review of the literature.
- Does race affect postoperative outcomes in patients with low-risk prostate Cancer who undergo radical prostatectomy?
- Transitional cell carcinoma of the fossa navicularis in a man with preexisting adenocarcinoma of the Prostate.
- Bladder cancer: Improvements in clinical staging of muscle-invasive Bladder cancer.
- Longitudinal evaluation of the concordance and prognostic value of lymphovascular invasion in transUrethral resection and radical cystectomy specimens.
- Impact of adjuvant chemotherapy on patients with lymph node metastasis at the time of radical cystectomy.
Schools
Perelman School of Medicine University of Pennsylvania
Procedures Preformed
- Cystectomy
- Cystourethroscopy and TransUrethral Resection of Bladder Neck
- Kidney and Ureter Removal
- Kidney Stone Removal (Percutaneous Nephrostolithotomy, PCNL)
- View All
Conditions Treated
- Bladder Atony
- Bladder Cancer
- Bladder Infection
- Blood in Urine (Hematuria)
- View All
Doctors Specialties
- Urology
Accepted Insurances
Education
-
Vanderbilt University -
University of Pennsylvania Health System -
Perelman School of Medicine at the University of Pennsylvania
Drug Facts
| NPI NUMBER | 1487710893 | |
| NPPES Provider LastName | RESNICK | |
| NPPES Provider FirstName | MATTHEW | |
| NPPES Provider ZIPCode | 372320001 | |
| NPPES Provider State | TN | |
| Specialty Description | Urology | |
| Total Claim Count | 37.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1487710893 |
| Last Name Of The Provider | RESNICK |
| First Name Of The Provider | MATTHEW |
| View All |
Similar Doctors
|
|
Dr. Melissa R. Kaufman, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Claude H. Workman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Christopher C. Hill, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert B. Barnett, MD |
|
|
Dr. John M. Tudor Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mark D. Flora, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Trisha M. Juliano, MD |
|
|
Dr. Lara M. Seltz, MD
This Doctor is OpenDoctor Recommended.
|